Cholesterol and lipid lowering effects and vascular action of p-chlororphenoxy-alpha-isobutyrate of 3-hydroxymethyl-pyridine-hydrochloric acid (clofinol)
Marmo, E.; Caputi, A.P.; Vacca, C.; Imperatore, A.; Cataldi, S.
La Clinica Terapeutica 68(6): 519-567
1974
ISSN/ISBN: 0009-9074 PMID: 4831379 Document Number: 75541
Document emailed within 1 workday
Related Documents
Tanamai, J.; Veeramanomai, S.; Indrakosas, N. 2004: The efficacy of cholesterol-lowering action and side effects of garlic enteric coated tablets in man Journal of the Medical Association of Thailand 87(10): 1156-1161Pearson, T.A.; Laurora, I.; Chu, H.; Kafonek, S. 2000: The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals Archives of Internal Medicine 160(4): 459-467
Stoy, N. 1997: Influence of cholesterol on survival after stroke. Beneficial effects of cholesterol lowering on atherosclerosis may not lessen with age Bmj 315(7116): 1158; Author Reply 1159
Lawless, C.; Force, R. 1997: Lipid lowering in post-Mi patients with normal cholesterol Journal of Family Practice 44(1): 30
Marmo, E.; Imperatore, A.M.; Caputi, A.; Cataldi, S. 1971: Hypocholesteremic and hypolipemic effects of p-chlorophenoxy-alpha-isobutyrate of 3-hydroxymethylpyridine hydrochloride Il Farmaco; Edizione Pratica 26(10): 557-584
Leitersdorf, E. 2002: Selective cholesterol absorption inhibition: a novel strategy in lipid-lowering management International Journal of Clinical Practice 56(2): 116-119
Basarkar, P.W.; Nath, N. 1981: Cholesterol lowering action of vitamin P-like compounds in rats Indian Journal of Experimental Biology 19(8): 787-789
Yamamoto, M.; Kumagai, A.; Yamamura, Y. 1975: Structure and action of saikosaponins isolated from Bupleurum falcatum L. II. Metabolic actions of saikosaponins, especially a plasma cholesterol-lowering action Arzneimittel-Forschung 25(8): 1240-1243
Ali, F.; Laurin, M.-Y.; Larivière, C.; Tremblay, D.; Cloutier, D. 2003: The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels Canadian Journal of Clinical Pharmacology 10(3): 101-106
2015: Switching from high-efficacy lipid-lowering therapies [atorvastatin or rosuvastatin] to simvastatin and the results on low-density lipoprotein cholesterol level Journal of the Medical Association of Thailand 98(1): 21-25
Praipaisarnkit, K.; Wongpraparut, N.; Pongakasira, R. 2014: Low-density lipoprotein cholesterol goal attainment among post myocardial infarction patients on lipid lowering therapy at Siriraj outpatient clinic Journal of the Medical Association of Thailand 97(Suppl 3): S147-S154
Forsythe, W.A.; Miller, E.R.; Hill, G.M.; Romsos, D.R.; Simpson, R.C. 1980: Effects of dietary protein and fat sources on plasma cholesterol parameters, LCAT activity and amino acid levels and on tissue lipid content of growing pigs Journal of Nutrition 110(12): 2467-2479
Imai, T.; Suzuki, S. 1971: Pyridine nucleotides. II. Isolation and identification of alpha-isomers of nicotinic acid mononucleotide and nicotinic acid-adenine dinucleotide Seikagaku. Journal of Japanese Biochemical Society 43(6): 346-362
Doehn, M.; Jungck, E. 1974: Side effects of the treatment of metabolic alkalosis with aminoacids and hydrochloric acid Der Anaesthesist 23(7): 299-301
Pike, N.B.; Wise, A. 2004: Identification of a nicotinic acid receptor: is this the molecular target for the oldest lipid-lowering drug? Current Opinion in Investigational Drugs 5(3): 271-275
Rosenthal, J. 1989: Blood pressure and lipid lowering effects of terazosin Journal of Human Hypertension 3 Suppl. 2: 85-9; Discussion 90-1
Wang, J.-b.; Xie, Y.; Pei, X.-r.; Yang, R.-y.; Zhang, Z.-f.; Li, Y. 2008: The lipid-lowering and antioxidative effects of marine collagen peptides Zhonghua Yu Fang Yi Xue Za Zhi 42(4): 226-230
Delloye, C.; Hebrant, A.; Coutelier, L. 1986: The effects of a long-term preservation of the bone inductive capacity of hydrochloric acid (HCl)-decalcified matrix Clinical Orthopaedics and Related Research 205: 309-310
2005: Lowering LDL cholesterol frequently does not adhere to guidelines. Also regard intestinal cholesterol source MMW Fortschritte der Medizin 147(23): 48-49
Takeda, M.; Takagi, T. 1980: Effects of a new bronchodilator, (alpha RS)-3-formamido-4-hydroxy-alpha-[[[(alpha RS)-p-methoxy-alpha-methylphenethyl] amino] methyl] benzyl alcohol fumarate dihydrate (BD 40A) on gastric acid secretion and gastrointestinal motility Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 76(3): 185-191